Fellowship Award
Groundbreaking research into diabetic retinopathy and telemedicine wins fellowship
Colin Kerr
Published: Tuesday, July 9, 2019
From left: Prof Peter Wiedemann (ICO President), Neeru Gupta (ICO Vice President),Dr Matias Iglicki, Prof Berthold Seitz (ICO Director of Fellowships)[/caption] A panel of leading experts has selected groundbreaking research into diabetic retinopathy and telemedicine as the winner of this year’s International Council of Ophthalmology (ICO) and Allergan Fellowship. Dr Matias Iglicki from the University of Buenos Aires in Argentina is the second recipient of the ICO-Allergan Fellowship Award. The award of a $50,000 grant, announced at the 2019 European Society of Ophthalmology meeting in Nice, France, will enable Dr Iglicki to continue his research into diabetic retinopathy and telemedicine, which he has been working on since 2004. https://www.allergan.ie/en-ie/home
Tags: allergan, diabetic retinopathy, telemedicine
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.